Amir Nashat, Director at FATE THERAPEUTICS INC (FATE), sold 191,581 shares at $14.16 ($2.7M) on 2019-01-29, disclosed to the SEC on 2019-01-31.
Open-market sale of $2.7M FATE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.16 | 644 | $9K | 0.3% |
| 2 | $14.16 | 941 | $13K | 0.5% |
| 3 | $14.16 | 1,834 | $26K | 1.0% |
| 4 | $14.16 | 94,081 | $1.3M | 49.1% |
| 5 | $14.16 | 94,081 | $1.3M | 49.1% |
| Total | $14.16 avg | 191,581 |
| $2.7M |
| 100% |
| Filing → |
| SRRK | BUY | 2022-06-24 | $6.2M | — | Filing → |
| MORF | SELL | 2021-05-25 | $20.4M | — | Filing → |
| MTCR | BUY | 2020-09-22 | $3.0M | — | Filing → |